X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4999) 4999
Book Chapter (7) 7
Dissertation (4) 4
Newspaper Article (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
eicosapentaenoic acid (3199) 3199
humans (3093) 3093
male (2384) 2384
animals (2000) 2000
female (1908) 1908
docosahexaenoic acid (1830) 1830
nutrition & dietetics (1426) 1426
eicosapentaenoic acid - administration & dosage (1310) 1310
omega-3 fatty acids (1251) 1251
fatty acids (1240) 1240
dietary supplements (1101) 1101
middle aged (1096) 1096
adult (1080) 1080
docosahexaenoic acids - administration & dosage (1043) 1043
fatty acids, omega-3 - administration & dosage (1034) 1034
polyunsaturated fatty-acids (1031) 1031
diet (885) 885
fish-oil (832) 832
unsaturated fatty acids (827) 827
lipids (826) 826
biochemistry & molecular biology (779) 779
aged (749) 749
rats (717) 717
eicosapentaenoic acid - pharmacology (692) 692
inflammation (663) 663
fish oils - administration & dosage (660) 660
fish oils (600) 600
supplementation (545) 545
fish oil (542) 542
double-blind method (539) 539
eicosapentaenoic acid - blood (537) 537
nutrition (528) 528
health aspects (495) 495
mice (491) 491
risk factors (480) 480
research (470) 470
omega-3-fatty-acids (467) 467
eicosapentaenoic acid - therapeutic use (462) 462
polyunsaturated fatty acids (451) 451
docosahexaenoic acids - blood (439) 439
docosahexaenoic acids - pharmacology (432) 432
metabolism (426) 426
alpha-linolenic acid (406) 406
fatty acids, omega-3 - pharmacology (396) 396
arachidonic acid (394) 394
endocrinology & metabolism (393) 393
treatment outcome (389) 389
cardiovascular-disease (387) 387
triglycerides - blood (377) 377
double-blind (366) 366
analysis (365) 365
physiological aspects (363) 363
fatty acids, omega-3 - therapeutic use (358) 358
fatty-acids (356) 356
risk (344) 344
plasma (330) 330
eicosapentaenoic acid - metabolism (329) 329
pharmacology & pharmacy (318) 318
cell biology (314) 314
oxidative stress (314) 314
dietary fats - administration & dosage (303) 303
prevention (302) 302
coronary-heart-disease (291) 291
n-3 fatty-acids (291) 291
fatty acids, unsaturated - administration & dosage (290) 290
dietary fats, unsaturated - administration & dosage (286) 286
cholesterol (281) 281
eicosapentaenoic acid - analogs & derivatives (279) 279
dose-response relationship, drug (278) 278
lipids - blood (278) 278
epa (276) 276
fatty acids, omega-3 - blood (276) 276
fatty acids, omega-3 - metabolism (275) 275
docosahexaenoic acids - metabolism (274) 274
rats, wistar (273) 273
life sciences (263) 263
arachidonic-acid (260) 260
young adult (260) 260
time factors (259) 259
docosahexaenoic acids - therapeutic use (257) 257
fish oils - pharmacology (257) 257
cardiovascular disease (251) 251
dha (251) 251
triglycerides (250) 250
fish (244) 244
adolescent (243) 243
omega-3 (242) 242
cardiac & cardiovascular systems (240) 240
disease (240) 240
care and treatment (239) 239
atherosclerosis (235) 235
fatty acids - blood (234) 234
disease models, animal (228) 228
gamma-linolenic acid (227) 227
rodents (227) 227
liver - metabolism (222) 222
biomarkers - blood (220) 220
n-3 (218) 218
cancer (216) 216
fish-oil supplementation (214) 214
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4922) 4922
Japanese (79) 79
German (30) 30
Russian (15) 15
Spanish (8) 8
Polish (6) 6
French (5) 5
Chinese (4) 4
Italian (4) 4
Hungarian (2) 2
Dutch (1) 1
Korean (1) 1
Portuguese (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Prostaglandins, leukotrienes and essential fatty acids, ISSN 0952-3278, 2013, Volume 88, Issue 1, pp. 139 - 146
Abstract The conversion of the plant-derived omega-3 (n-3) α-linolenic acid (ALA, 18:3n-3) to the long-chain eicosapentaenoic acid... 
Endocrinology & Metabolism | Advanced Basic Science | Docosahexaenoic acid (DHA) | Alpha linolenic acid (ALA) | LA:ALA ratio | Linoleic acid (LA) | RAT-LIVER | CONVERSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | HUMANS | CELL BIOLOGY | TERM INFANTS | VISUAL-ACUITY DEVELOPMENT | PLASMA | BIOSYNTHESIS | GROWTH | ENDOCRINOLOGY & METABOLISM | FISH-OIL | EICOSAPENTAENOIC ACID | Linoleic Acid - blood | Linoleic Acid - administration & dosage | Fatty Acids, Omega-6 - blood | Rats, Wistar | alpha-Linolenic Acid - analysis | Linoleic Acid - metabolism | Weaning | Safflower Oil - chemistry | Diet, High-Fat - adverse effects | Safflower Oil - metabolism | Male | Safflower Oil - administration & dosage | Linoleic Acid - adverse effects | Fatty Acids, Essential - deficiency | Fatty Acids, Essential - blood | Phospholipids - blood | Fatty Acids, Unsaturated - analysis | Phospholipids - metabolism | Plant Oils - administration & dosage | alpha-Linolenic Acid - administration & dosage | alpha-Linolenic Acid - blood | Fatty Acids, Essential - metabolism | Safflower Oil - adverse effects | Eicosapentaenoic Acid - metabolism | Phospholipids - chemistry | Rats | Fatty Acids, Omega-6 - metabolism | Linseed Oil - chemistry | Plant Oils - adverse effects | Eicosapentaenoic Acid - blood | Fatty Acids, Unsaturated - blood | Algorithms | Animals | Docosahexaenoic Acids - blood | Fatty Acids, Omega-6 - chemistry | Sunflower Oil | Linseed Oil - metabolism | Diet, Fat-Restricted | Fatty Acids, Unsaturated - adverse effects | Plant Oils - metabolism | alpha-Linolenic Acid - metabolism | Plant Oils - chemistry | Linseed Oil - administration & dosage | Docosahexaenoic Acids - metabolism | Fatty Acids, Omega-6 - adverse effects | Fatty Acids, Unsaturated - administration & dosage | Omega-3 fatty acids | Linolenic acids
Journal Article
The American journal of clinical nutrition, ISSN 1938-3207, 2011, Volume 93, Issue 5, pp. 950 - 962
Journal Article
Journal Article
Journal Article
Nutrients, ISSN 2072-6643, 2017, Volume 9, Issue 4, p. 325
Journal Article
Vascular health and risk management, ISSN 1178-2048, 2013, Volume 9, Issue 1, pp. 563 - 573
The systemic bioavailability of free fatty acid (FFA) forms of eicosapentaenoic acid (EPA... 
Docosahexaenoic acid | Pharmacokinetics | Hypertriglyceridemia | Eicosapentaenoic acid | Esters - adverse effects | Area Under Curve | Cholesterol - blood | Humans | Eicosapentaenoic Acid - adverse effects | Fatty Acids, Omega-3 - chemistry | Biological Availability | Fatty Acids, Nonesterified - administration & dosage | Male | Eicosapentaenoic Acid - administration & dosage | Esters - chemistry | Fatty Acids, Nonesterified - blood | Female | Fatty Acids, Nonesterified - adverse effects | Fatty Acids, Omega-3 - administration & dosage | Eicosapentaenoic Acid - chemistry | Administration, Oral | Docosahexaenoic Acids - chemistry | Docosahexaenoic Acids - administration & dosage | Docosahexaenoic Acids - pharmacokinetics | Chemistry, Pharmaceutical | Fatty Acids, Nonesterified - pharmacokinetics | Eicosapentaenoic Acid - blood | Fatty Acids, Omega-3 - pharmacokinetics | Docosahexaenoic Acids - blood | Models, Biological | Diet, Fat-Restricted | Eicosapentaenoic Acid - pharmacokinetics | Esters - administration & dosage | Triglycerides - blood | Esters - blood | Fatty Acids, Nonesterified - chemistry | Least-Squares Analysis | Fatty Acids, Omega-3 - blood | Esters - pharmacokinetics | Dietary Supplements | Docosahexaenoic Acids - adverse effects | Fatty Acids, Omega-3 - adverse effects | Drug Combinations | Care and treatment | Usage | Hyperlipidemia | Statistics | Fatty acids | Health aspects | Low-fat diet | Cardiovascular disease | Bioavailability | Diet | hypertriglyceridemia | pharmacokinetics | eicosapentaenoic acid | Original Research | docosahexaenoic acid
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140884
Arachidonic acid (ARA) metabolites produced by cyclo-oxygenase and lipoxygenase are important mediators maintaining physiological renal function... 
CYCLOOXYGENASE-2 | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | MESANGIAL CELLS | INJURY | POLYUNSATURATED FATTY-ACIDS | RENAL ISCHEMIA-REPERFUSION | LIPID MEDIATORS | PROTECTIN D1 | EXPRESSION | AGING KIDNEY | Kidney - drug effects | Rats, Wistar | Reactive Oxygen Species - blood | Eicosapentaenoic Acid - analogs & derivatives | Eicosapentaenoic Acid - metabolism | Rats | Arachidonic Acid - administration & dosage | Eicosapentaenoic Acid - blood | Fatty Acids, Unsaturated - blood | Kidney - metabolism | Animals | Docosahexaenoic Acids - blood | Creatinine - blood | Aging - metabolism | Cytokines - blood | Docosahexaenoic Acids - metabolism | Metabolites | Analysis | Physiological aspects | Research | Arachidonic acid | Mass spectrometry | Omega-3 fatty acids | Cytochrome | Oxidative stress | Plasma | Reactive oxygen species | Physiological effects | Renal function | Liver | Body weight | Lipid peroxidation | Prostaglandin E2 | Eicosanoids | Lipids | Kinases | Docosahexaenoic acid | Prostaglandin endoperoxide synthase | Proteins | Ischemia | Rodents | Tumor necrosis factor-TNF | Physiology | Peroxidation | Creatinine | Oxygen | Kidneys | Cytokines | Oral administration | Mass spectroscopy | Liquid chromatography | Inflammation | Nitrogen | Fatty acids | Chromatography | Medicine | Oxygenase | Urea | Diet | Acids | Electrolytes | In vivo methods and tests | University faculty | Lipoxygenase | Laboratory animals | Eicosapentaenoic acid
Journal Article
Journal of Psychiatric Research, ISSN 0022-3956, 2014, Volume 57, Issue 1, pp. 58 - 64
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2009, Volume 54, Issue 7, pp. 585 - 594
Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in primary and, particularly in secondary prevention of cardiovascular (CV) diseases... 
Cardiovascular | Internal Medicine | ω-3 polyunsaturated fatty acids | fish oils | cardiovascular diseases | CARDIAC & CARDIOVASCULAR SYSTEMS | RATE-VARIABILITY | MYOCARDIAL-INFARCTION | omega-3 polyunsaturated fatty acids | ATRIAL-FIBRILLATION | PLASMA-LIPIDS | DOCOSAHEXAENOIC ACID | ADIPONECTIN SECRETION | FISH-OIL | CORONARY-HEART-DISEASE | EICOSAPENTAENOIC ACID | ALPHA-LINOLENIC ACID | Prognosis | Cardiovascular Diseases - prevention & control | Humans | Eicosapentaenoic Acid - administration & dosage | Secondary Prevention | Heart Failure - prevention & control | Fishes | Cardiovascular Diseases - mortality | Fish Oils - administration & dosage | Fatty Acids, Omega-3 - administration & dosage | Heart Failure - mortality | Cardiomyopathies - drug therapy | Docosahexaenoic Acids - therapeutic use | Cardiovascular Diseases - physiopathology | Atherosclerosis - drug therapy | Heart Conduction System - drug effects | Docosahexaenoic Acids - administration & dosage | Randomized Controlled Trials as Topic | Arrhythmias, Cardiac - drug therapy | Coronary Disease - prevention & control | Animals | Diet | Heart Conduction System - physiopathology | Fatty Acids, Omega-3 - therapeutic use | Eicosapentaenoic Acid - therapeutic use | Seafood - analysis | Heart failure | Prosthesis | Implants, Artificial | Cardiac patients | Low density lipoproteins | Atrial fibrillation | Linolenic acids | Omega-3 fatty acids | Heart attack | Prevention | Medical colleges | Unsaturated fatty acids | Studies | Vegetable oils | Heart attacks | Fish oils | Mortality | Oils & fats | Fatty acids
Journal Article
British Journal of Nutrition, ISSN 0007-1145, 08/2013, Volume 110, Issue 3, pp. 559 - 568
Journal Article